Investigation of The Effect of Aminoglycosides on Angiotensin Converting Enzyme (ACE)

Abstract

Objective: The research attention to nephrotoxicity from antibiotics (as aminoglycosides), non-steroidal anti-inflammatory drugs, and antifungals, angiotensin-converting enzyme (ACE) inhibitors. Several drugs have resulted in produce an adverse effect on kidneys. Angiotensin-converting enzyme (ACE) is a component of the renin-angiotensin system (RAS), which leads to the conversion of angiotensin-I to angiotensin-II in vascular tissues. The present study aimed to determine serum ACE activity in rats with an aminoglycosine. Material-Method: In this study, two different groups formed, the control group (10 rats/Wistar-albino female) and the experimental group (30 rats/Wistar-albino female) administered aminoglycosine (Amikacin). Aminoglycosine was administered intraperitoneally to the experimental group at a single dose of 15 mg/kg body weight at the same time each day for 14 days. The control group implemented physiological water instead of aminoglycosine at the same rate. Result: When the groups compared according to the statistic results, it is observed that there was a significant increase in the experimental group according to the control group (p˂0.001). Conclusion: As a result, it was determined that aminoglycosin administered increased serum ACE activity and it was concluded that it may be useful to investigate the possibilities to evaluate it as a risk factor and indicator in the development of hypertension

Keywords

• Aminoglycosides
• Angiotensin-Converting Enzyme
• Antibiotics

References

1. Alimoradian A, Changizi-Ashtiyani S, Farahani AG, Kheder L, Rajabi R, Sharifi A. Protective Effects of Pomegranate Juice on Nephrotoxicity Induced By Captopril and Gentamicin in Rats. Iran J Kidney Dis. 2017;11(6):422-9.
2. Anonymous, Hipertansiyonda Korunma ve Tedavi. Available at: https://tkd.org.tr/kilavuz/k03/4_2c93c.htm?wbnum=1107. Accessed Jan 05, 2020.
3. Aygün G. Akılcı Antibiyotik Kullanımı ve Erişkinde Toplumdan Edinilmiş Enfeksiyonlar Sempozyum Dizisi. Cerrahpaşa Tıp Fakültesi Sürekli Tıp Eğitimi Etkinlikleri. 2002;31:39-54.
4. Balcı-Ekmekçi Ö, Donma O, Aydemir A, Özdemir S, Bağrıaçık N. Hipertansif Diyabetik Bireylerin Plazma Anjiotensin Dönüştürücü Enzim Aktivitesi ile Plazma ve Eritrosit Çinko Düzeyleri. Turkiye Klinikleri J Med Sci. 2002;22(6):553-6.
5. Bénéteau-Burnat B1, Baudin B. Angiotensin-Converting Enzyme: Clinical Applications And Laboratory Investigations on Serum and Other Biological Fluids. Crit Rev Clin Lab Sci. 1991;28(5-6):337-56.
6. Burnier M. Angiotensin II Type 1 Receptor Blockers. Circulation. 2001;103:904-12.
7. Caner E, Deger Y. Lipid Peroxidation, Antioxidant Profile And Some Biochemical Parameters in Rat Applied Aminoglycoside. World J Pharm Pharm Sci. 2018;7(1):169-79.
8. Dzau VJ, Bernstein K, Celermajer D, Cohen J, Dahlöf B, Deanfield J, et al. The Relevance of Tissue Angiotensin-Converting Enzyme: Manifestations in Mechanistic And End Point Data. Am J Cardiol. 2001;88(9A):1-20.

9. Ecder T. Renin İnhibisyonu ve Böbrek. Arch Turk Soc Cardiol. 2009;37(7):28-31.
10. Eriguchi M, Lin M, Yamashita M, Zhao TV, Khan Z, Bernstein EA, et al. Renal Tubular ACE-Mediated Tubular İnjury is the Major Contributor to Microalbuminuria in Early Diabetic Nephropathy. Am J Physiol Renal Physiol. 2018;314:531-42.
11. Falkenhahn M, Franke F, Bohle RM, Zyu Y-C, Stauss HM, Bachmann S, et al. Cellular Distribution of Angiotensin-Converting Enzyme After Myocardial Infraction. Hypertension. 1995;25(2):219-26.
12. Fauconneau B, Tallineau C, Huguet F, Piriou A. Gentamicin Induced Kidney Damage and Lipid Peroxidation in Rats. Toxicology Lett. 1995;76:127-34.
13. Humes HD. Aminoglycoside Nephrotoxicity. Kidney Int. 1988;33(4):900-11.
14. Liu M-H, Floten HS, Furnary AP, Yim APC, He G-W. Inhibition of Vasoconstriction by Angiotensin Receptor Antagonist GR117289C in Arterial Grafts. Ann Thorac Surg. 2000;70:2064-69.
15. Ma C, Xin H, Jiang X-Y, Wang Y-X, Zhang Y-S. Relationship Between Renal İnjury and the Antagonistic Roles of Angiotensin-Converting Enzyme (ACE) and ACE2. Genet Mol Res. 2014;13(2):2333-42.
16. Mıstık R. Aminoglikozid Antibiyotikler ve Günde Tek Doz Kullanımları. Klimik Derg. 2000; l:43-5.
17. Moncada S, Palmer RMJ, Higs EA. The Discovery of Nitric oxide As the Endogenous Nitro Vasodilator. Hypertension. 1998;12:365-72.
18. Ozmutlu S, Dede S, Ceylan E. The Effect of Lycopene Treatment on ACE Activity in Rats with Experimental Diabetes. J Renin-Angio-Aldo S. 2012;13(3):328-33.
19. Paller MS. Drug-Induced Nephropaties. Med Clin North America. 1991;74(4):909-1001.
20. Singhal M, Prajapati B. In Vivo Evaluation of Aminoglycoside Induced Nephrotoxicity and Hepatotoxicity in Albino Rats. Pharmacologyonline. 2011;2:451-57.
21. Siragy HM, Carey RM. Role of the Intrarenal Renin-Angiotensin-Aldosterone System in Chronic Kidney Disease. Am J Nephrol. 2010;31(6):541-50.
22. Yanagida C, Ito K, Komiya I, Horie T. Protective Effect of Fosfomycin on Gentamicin-Induced Lipid Peroxidation of Rat Renal Tissue. Chem Biol Interac. 2004;148(3):139-47.
23. Ziai SA, Mooraki A, Mahmoudian M. Gentamicin Reduces Serum Ace Activity in Patients with Normal Kidney Function. Am J Nephrol. 2002;22:487-90.
24. Ziai SA, Salehian P, Mahmoudian M. Study of Serum And Tissues Angiotensin-Converting Enzyme (ACE) Activity in Rat with Gentamicin Induced Renal Toxicity. Ren Fail. 2003;25(6):923-33.